Biodexa Pharmaceticals Stock Volatility Indicators Average True Range
| BDRX Stock | 4.57 0.17 3.86% |
| Symbol |
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biodexa Pharmaceticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Biodexa Pharmaceticals Technical Analysis Modules
Most technical analysis of Biodexa Pharmaceticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biodexa from various momentum indicators to cycle indicators. When you analyze Biodexa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biodexa Pharmaceticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biodexa Pharmaceticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biodexa Pharmaceticals based on widely used predictive technical indicators. In general, we focus on analyzing Biodexa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biodexa Pharmaceticals's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Biodexa Pharmaceticals's intrinsic value. In addition to deriving basic predictive indicators for Biodexa Pharmaceticals, we also check how macroeconomic factors affect Biodexa Pharmaceticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 20.84 | 171.8 | 197.56 | 290.21 | PTB Ratio | 29.89 | 25.45 | 0.36 | 0.34 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Biodexa Stock Analysis
When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.